搜索结果: 1-4 共查到“生物医学工程 non-small cell lung cancer”相关记录4条 . 查询时间(0.038 秒)
Current status of Radiologic Diagnosis for Mediastinal Lymph Node Metastases of Non-Small-Cell Lung Cancer: Retrospective Study of pN2 Cases
Non-Small-Cell Lung Cancer Mediastinal Lymph Node Metastasis
2013/2/19
Objective: Advances in diagnostic imaging techniques, such as 18F-fluorodeoxyglucose positron emission tomography (FDG-PET), have led to greater accuracy in preoperative mediastinal staging for patien...
A phase I study with Satraplatin and simultaneous chest radiation for non-small cell lung cancer
Non-Small Cell Lung Cancer Chemoradiation Satraplatin Phase I Study Toxicity
2013/1/29
Introduction: Satraplatin has been given in combination therapy for lung cancer to utilize its radio-sensitizing properties. The optimal dose of satra-platin given concurrently with radiation therapy ...
Prognostic Values of PET/CT Findings and Tumor/Patient Characteristics with Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer Survival Prognosis Positron Emission Tomography (PET) FDG-PET
2013/1/31
Background/Aim: Although numerous prognostic factors have been described for non-small cell lung cancer (NSCLC), there is still a requirement for better and non-invasive markers. FDG-PET is a non inva...
Analysis of Cisplatin Behavior in a Non-Small Cell Lung Cancer（NSCLC）Cell Line
cisplatin resistance NSCLC intracellular Pt accumulation Pt-DNA adduct
2009/3/23
Cisplatin (CDDP) is an effective anticancer agent that is widely used in the treatment of testicular, ovarian, bladder and lung cancers. However the development of resistance to CDDP by tumor cells is...